-
1
-
-
67349228199
-
Genetics of rheumatoid arthritis: Underlying evidence of ethnic differences
-
Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun 2009; 32:158-62.
-
(2009)
J Autoimmun
, vol.32
, pp. 158-162
-
-
Kochi, Y.1
Suzuki, A.2
Yamada, R.3
Yamamoto, K.4
-
2
-
-
0031974911
-
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
-
Schellekens GA, De Jong BA, Van den Hoogen FH, Van de Putte LB, Van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101:273-81. (Pubitemid 28058927)
-
(1998)
Journal of Clinical Investigation
, vol.101
, Issue.1
, pp. 273-281
-
-
Schellekens, G.A.1
De Jong, B.A.W.2
Van Den, H.F.H.J.3
Van De, P.L.B.A.4
Van Venrooij, W.J.5
-
3
-
-
33750817321
-
Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis
-
DOI 10.1016/j.autrev.2006.03.008, PII S1568997206000395
-
Van Venrooij WJ, Zendman AJW, Pruijn GJM. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 2006; 6:37-41 (Pubitemid 44716772)
-
(2006)
Autoimmunity Reviews
, vol.6
, Issue.1
, pp. 37-41
-
-
Van Venrooij, W.J.1
Zendman, A.J.W.2
Pruijn, G.J.M.3
-
4
-
-
60349127531
-
Complement activation and inhibition: A delicate balance
-
Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol 2009; 30:83-90.
-
(2009)
Trends Immunol
, vol.30
, pp. 83-90
-
-
Sjoberg, A.P.1
Trouw, L.A.2
Blom, A.M.3
-
5
-
-
34548849168
-
TRAF1-C5 as a risk locus for rheumatoid arthritis - A genomewide study
-
DOI 10.1056/NEJMoa073491
-
Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007; 357:1199-209. (Pubitemid 47443179)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.12
, pp. 1199-1209
-
-
Plenge, R.M.1
Seielstad, M.2
Padyukov, L.3
Lee, A.T.4
Remmers, E.F.5
Ding, B.6
Liew, A.7
Khalili, H.8
Chandrasekaran, A.9
Davies, L.R.L.10
Li, W.11
Tan, A.K.S.12
Bonnard, C.13
Ong, R.T.H.14
Thalamuthu, A.15
Pettersson, S.16
Liu, C.17
Tian, C.18
Chen, W.V.19
Carulli, J.P.20
Beckman, E.M.21
Altshuler, D.22
Alfredsson, L.23
Criswell, L.A.24
Amos, C.I.25
Seldin, M.F.26
Kastner, D.L.27
Klareskog, L.28
Gregersen, P.K.29
more..
-
6
-
-
67650065027
-
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways
-
Trouw LA, Haisma EM, Levarht EW, et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009; 60:1923-31.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 1923-1931
-
-
Trouw, L.A.1
Haisma, E.M.2
Levarht, E.W.3
-
7
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24 (Pubitemid 18091653)
-
(1988)
Arthritis and Rheumatism
, vol.31
, Issue.3
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
Healey, L.A.7
Kaplan, S.R.8
Liang, M.H.9
Luthra, H.S.10
Medsger Jr., T.A.11
Mitchell, D.M.12
Neustadt, D.H.13
Pinals, R.S.14
Schaller, J.G.15
Sharp, J.T.16
Wilder, R.L.17
Hunder, G.G.18
-
8
-
-
5444231338
-
Remission in rheumatoid arthritis: Agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
-
DOI 10.1093/rheumatology/keh297
-
Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43:1252-5 (Pubitemid 39359299)
-
(2004)
Rheumatology
, vol.43
, Issue.10
, pp. 1252-1255
-
-
Fransen, J.1
Creemers, M.C.W.2
Van Riel, P.L.C.M.3
-
9
-
-
0030068817
-
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria
-
DOI 10.1002/art.1780390105
-
Van Gestel AM, Prevoo ML, Van 't Hof MA, Van Rijswijk MH, Van de Putte LB, Van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39:34-40. (Pubitemid 26036375)
-
(1996)
Arthritis and Rheumatism
, vol.39
, Issue.1
, pp. 34-40
-
-
Van Gestel, A.M.1
Prevoo, M.L.L.2
Van't, H.M.A.3
Van Rijswijk, M.H.4
Van De, P.L.B.A.5
Van Riel, P.L.C.M.6
-
10
-
-
79957812587
-
Inhibition of the complement system by glutathione: Molecular mechanisms and potential therapeutic implications
-
Perricone C, De Carolis C, Giacomelli R, Greco E, Cipriani P, Ballanti E, Novelli L, Perricone R. Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications. Int J Immunopathol Pharmacol 2011; 24:63-8.
-
(2011)
Int J Immunopathol Pharmacol
, vol.24
, pp. 63-68
-
-
Perricone, C.1
De Carolis, C.2
Giacomelli, R.3
Greco, E.4
Cipriani, P.5
Ballanti, E.6
Novelli, L.7
Perricone, R.8
-
11
-
-
4444225379
-
Hereditary and acquired angioedema: Problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
-
Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-131.
-
(2004)
J Allergy Clin Immunol
, vol.114
-
-
Agostoni, A.1
Aygören-Pürsün, E.2
Binkley, K.E.3
-
12
-
-
0033978323
-
Impaired human ovarian follicular fluid complement function in hereditary angioedema
-
DOI 10.1046/j.1365-3083.2000.00652.x
-
Perricone R, De Carolis C, Giacomello F, Giacomelli R, De Sanctis G, Fontana L. Impaired human ovarian follicular fluid complement function in hereditary angioedema. Scand J Immunol 2000; 51:104-8. (Pubitemid 30074311)
-
(2000)
Scandinavian Journal of Immunology
, vol.51
, Issue.1
, pp. 104-108
-
-
Perricone, R.1
De Carolis, C.2
Giacomello, F.3
Giacomelli, R.4
De Sanctis, G.5
Fontana, L.6
-
13
-
-
0022994184
-
Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a
-
DOI 10.1002/art.1780291103
-
Watson WC, Cremer MA, Wooley PH, Townes AS. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis: evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum 1986; 29:1316-21 (Pubitemid 17214031)
-
(1986)
Arthritis and Rheumatism
, vol.29
, Issue.11
, pp. 1316-1321
-
-
Watson, W.C.1
Cremer, M.A.2
Wooley, P.H.3
Townes, A.S.4
-
14
-
-
0026354378
-
Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis
-
Brodeur JP, Ruddy S, Schwartz LB, Moxley G. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:1531 -7.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1531-1537
-
-
Brodeur, J.P.1
Ruddy, S.2
Schwartz, L.B.3
Moxley, G.4
-
15
-
-
0023001135
-
Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis
-
DOI 10.1002/art.1780291108
-
Mollnes TE, Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29:1359-64. (Pubitemid 17214036)
-
(1986)
Arthritis and Rheumatism
, vol.29
, Issue.11
, pp. 1359-1364
-
-
Mollnes, T.E.1
Paus, A.2
-
16
-
-
33646368660
-
Evaluation of classical complement pathway activation in rheumatoid arthritis: Measurement of C1q-C4 complexes as novel activation products
-
DOI 10.1002/art.21729
-
Wouters D, Voskuyl AE, Molenaar ET, Dijkmans BA, Hack CE. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Arthritis Rheum 2006; 54:1143-50. (Pubitemid 43672927)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.4
, pp. 1143-1150
-
-
Wouters, D.1
Voskuyl, A.E.2
Molenaar, E.T.H.3
Dijkmans, B.A.C.4
Hack, C.E.5
-
17
-
-
0036226744
-
Local production of complement proteins in rheumatoid arthritis synovium
-
DOI 10.1002/art.10183
-
Neumann E, Barnum SR, Tarner IH, et al. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 2002; 46:934-45. (Pubitemid 34303805)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.4
, pp. 934-945
-
-
Neumann, E.1
Barnum, S.R.2
Tarner, I.H.3
Echols, J.4
Fleck, M.5
Judex, M.6
Kullmann, F.7
Mountz, J.D.8
Scholmerich, J.9
Gay, S.10
Muller-Ladner, U.11
-
18
-
-
0034052961
-
Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis
-
Aggarwal A, Bhardwaj A, Alam S, Misra R. Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford). 2000; 39:189-92. (Pubitemid 30139354)
-
(2000)
Rheumatology
, vol.39
, Issue.2
, pp. 189-192
-
-
Aggarwal, A.1
Bhardwaj, A.2
Alam, S.3
Misra, R.4
-
19
-
-
54549121675
-
Clearance deficiency - A potential link between infections and autoimmunity
-
Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, Herrmann M. Clearance deficiency - a potential link between infections and autoimmunity. Autoimmun Rev 2008; 8:5-8.
-
(2008)
Autoimmun Rev
, vol.8
, pp. 5-8
-
-
Schulze, C.1
Munoz, L.E.2
Franz, S.3
Sarter, K.4
Chaurio, R.A.5
Gaipl, U.S.6
Herrmann, M.7
-
20
-
-
77955293575
-
Predictors for remission in rheumatoid arthritis patients: A systematic review
-
Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C. Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care Res (Hoboken) 2010; 62:1128-43.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 1128-1143
-
-
Katchamart, W.1
Johnson, S.2
Lin, H.J.3
Phumethum, V.4
Salliot, C.5
Bombardier, C.6
-
21
-
-
38649098475
-
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
-
DOI 10.1002/art.23247
-
Burmester GR, Ferraccioli G, Flipo RM, et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 2008; 59:32-41. (Pubitemid 351171876)
-
(2008)
Arthritis Care and Research
, vol.59
, Issue.1
, pp. 32-41
-
-
Burmester, G.R.1
Ferraccioli, G.2
Flipo, R.-M.3
Monteagudo-Saez, I.4
Unnebrink, K.5
Kary, S.6
Kupper, H.7
-
22
-
-
70449516048
-
Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
-
De Vries MK, Van Eijk IC, Van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum 2009; 61:1484-90.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 1484-1490
-
-
De Vries, M.K.1
Van Eijk, I.C.2
Van Der Horst-Bruinsma, I.E.3
Peters, M.J.4
Nurmohamed, M.T.5
Dijkmans, B.A.6
Hazenberg, B.P.7
Wolbink, G.J.8
-
23
-
-
0025995227
-
Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: Quantitative analysis and effect of intraarticular corticosteroids
-
Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34:1094-105
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1094-1105
-
-
Firestein, G.S.1
Paine, M.M.2
Littman, B.H.3
-
24
-
-
10344229927
-
Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: Further evidence of inflammatory activation
-
DOI 10.1136/hrt.2003.017327
-
Sampietro T, Bigazzi F, Dal Pino B, et al. Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalpha lipoproteinaemia: further evidence of inflammatory activation. Heart 2004; 90:1438-42. (Pubitemid 39626321)
-
(2004)
Heart
, vol.90
, Issue.12
, pp. 1438-1442
-
-
Sampietro, T.1
Bigazzi, F.2
Dal, P.B.3
Rossi, G.4
Chella, E.5
Lusso, S.6
Puntoni, M.7
Tuoni, M.8
Bionda, A.9
-
25
-
-
8644277199
-
Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women
-
DOI 10.1016/j.atherosclerosis.2004.07.022, PII S0021915004003946
-
Széplaki G, Prohászka Z, Duba J, et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 2004; 177:383-9. (Pubitemid 39505272)
-
(2004)
Atherosclerosis
, vol.177
, Issue.2
, pp. 383-389
-
-
Szeplaki, G.1
Prohaszka, Z.2
Duba, J.3
Rugonfalvi-Kiss, S.4
Karadi, I.5
Kokai, M.6
Kramer, J.7
Fust, G.8
Kleiber, M.9
Romics, L.10
Varga, L.11
-
26
-
-
63749093322
-
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
-
Kaymakcalan Z, Sakorafas P, Bose S, Scesney S, Xiong L, Hanzatian DK, Salfeld J, Sasso EH. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 2009; 131:308-16.
-
(2009)
Clin Immunol
, vol.131
, pp. 308-316
-
-
Kaymakcalan, Z.1
Sakorafas, P.2
Bose, S.3
Scesney, S.4
Xiong, L.5
Hanzatian, D.K.6
Salfeld, J.7
Sasso, E.H.8
|